News

Securing a future where life-saving treatments remain effective: In 2019, WHO identified AMR as one of the top ten global public health threats, jeopardizing our ability to treat common infections and perform routine medical procedures. Without urgent action, drug-resistant infections could claim 39 million lives by 2050 and cost up to USD 412 billion annually, disproportionately affecting vulnerable populations and low-resource settings.